Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing
Condition(s):Fabry DiseaseLast Updated:May 6, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Fabry DiseaseLast Updated:May 6, 2023Recruiting
Condition(s):Fabry DiseaseLast Updated:February 14, 2024Recruiting
Condition(s):Fabry DiseaseLast Updated:April 14, 2023Recruiting
Condition(s):Fabry Disease; AmyloidosisLast Updated:May 20, 2021Unknown status
Condition(s):Fabry DiseaseLast Updated:October 4, 2023Recruiting
Condition(s):Fabry Disease; NephropathyLast Updated:August 3, 2023Recruiting
Condition(s):Fabry DiseaseLast Updated:November 18, 2023Recruiting
Condition(s):Fabry Disease; Chronic Kidney DiseasesLast Updated:March 22, 2024Not yet recruiting
Condition(s):Fabry DiseaseLast Updated:February 8, 2024Recruiting
Condition(s):Angiokeratomas; Chronic Kidney Disease; Ocular Abnormalities; Hearing LossLast Updated:February 13, 2023Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.